The Lancet: March 07, 2008

In this week's podcast, Martin Bachmann discusses results of a phase II study showing how a vaccine to inhibit angiotensin II is safe and well tolerated; the vaccine also shows promising results in reducing blood pressure for people with hypertension. Authors of a Comment state: "Vaccination for hypertension may turn out to be very useful in many patients." Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://fa...

Om Podcasten

Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.